2m 2m 2m 2m 2m 2m 2m
EVOTEC SP ADS (EVO)
NASDAQ
$2.90-$0.06 (-1.86%)
Price as of Jun 03, 2026 5:51 PM EDT- $1.1BMarket Cap
- -26.80%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOTEC SP ADS (EVO)
$2.90-$0.06 (-1.86%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 788.4M -1.08% | 797.0M +1.99% | 781.4M +3.99% | 751.4M +21.59% | |
Cost of Revenue | 674.2M -1.16% | 682.1M +12.49% | 606.4M +5.02% | 577.4M +23.77% | |
Gross Profit | 114.2M -0.57% | 114.9M -34.37% | 175.1M +0.57% | 174.1M +14.86% | |
Sales and Marketing Expense | 176.0M -6.50% | 188.2M +10.96% | 169.6M +8.59% | 156.2M +48.12% | |
Research and Development Expense | -37.5M -26.25% | -50.9M -25.79% | -68.5M -10.59% | -76.6M +6.15% | |
Depreciation and Amortization Expense | 99.5M -2.11% | 101.6M +9.29% | 93.0M N/A | N/A N/A | |
Total Operating Expenses | 176.0M -6.50% | 188.2M +10.96% | 169.6M +8.59% | 156.2M +48.12% | |
Operating Profit | -56.2M -60.56% | -142.5M +200.00% | -47.5M -327.85% | 20.9M -49.14% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 143,000 +70.24% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -13.2M +42.10% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -13.0M +41.84% | |
Total Nonoperating Income and Expense | 65.6M +24.48% | 52.7M -18.66% | 64.8M +45,209.79% | 143,000 +70.24% | |
Income before Taxes | -103.5M -47.21% | -196.1M +133.67% | -83.9M -52.23% | -175.7M -181.51% | |
Income Taxes | 16.8M +696.91% | 2.1M -36.69% | 3.3M -84.70% | 21.7M +1.06% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -103.5M -47.21% | -196.1M +133.67% | -83.9M -52.23% | -175.7M -181.51% | |
Net Income from Continuing Operations Applicable to Common | -103.5M -47.21% | -196.1M +133.67% | -83.9M -52.23% | -175.7M -181.51% | |
Basic EPS and Net Income | -0.58 -47.75% | -1.11 +136.17% | -0.47 -52.53% | -0.99 -176.15% | |
Diluted EPS and Net Income | -0.58 -47.75% | -1.11 +136.17% | -0.47 -52.53% | -0.99 -176.15% | |
Basic Weighted Average Shares | 177.6M +0.16% | 177.3M +0.21% | 176.9M +0.14% | 176.7M +6.17% | |
Diluted Weighted Average Shares | 177.6M +0.16% | 177.3M +0.21% | 176.9M +0.14% | 176.7M +6.17% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 418.5M +36.60% | 306.4M -40.03% | 510.9M +23.06% | 415.2M -40.63% | |
Short-Term Investments | 57.9M -35.99% | 90.4M -2.99% | 93.2M -69.27% | 303.3M +90.89% | |
Cash and Cash Equivalents and Short-Term Investments | 476.4M +20.06% | 396.8M -34.32% | 604.1M -15.92% | 718.5M -16.28% | |
Total Current Assets | 762.9M +11.87% | 682.0M -24.49% | 903.2M -15.88% | 1.1B -2.48% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | 650.2M +34.17% | |
Total Long-Term Assets | 951.0M -22.72% | 1.2B -8.80% | 1.3B +14.00% | 1.2B +4.35% | |
Total Assets | 1.7B -10.38% | 1.9B -15.09% | 2.3B -0.21% | 2.3B +0.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 81.5M +200.58% | 27.1M -79.14% | 130.0M N/A | N/A N/A | |
Total Current Liabilities | 368.1M +6.82% | 344.6M -25.83% | 464.6M +37.57% | 337.7M +4.06% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 532.2M -13.52% | 615.4M -7.87% | 668.0M -8.79% | 732.4M +37.41% | |
Total Liabilities | 42.1M +13,449.20% | 311,000 0.00% | 311,000 +1.63% | 306,000 -72.26% | |
Retained Earnings | -775.9M +15.40% | -672.4M +41.17% | -476.3M +21.39% | -392.4M +81.30% | |
Total Stockholders Equity | 813.7M -14.57% | 952.5M -14.95% | 1.1B -5.67% | 1.2B -13.83% | |
Total Shares Outstanding | 177.8M +0.13% | 177.6M +0.21% | 177.2M +0.13% | 177.0M +0.20% | |
Cash Flow | |||||
Cash from Operating Activities | -9.2M -150.38% | 18.2M -50.00% | 36.4M -82.06% | 203.1M +66.16% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 171.6M +341.04% | -71.2M +435.60% | -13.3M -96.80% | -415.8M +70.52% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -37.6M -76.69% | -161.4M -324.31% | 72.0M +237.30% | -52.4M -113.16% | |
Financials Ratio | |||||
Gross Margin | 14.49% +0.51% | 14.41% -35.65% | 22.40% -3.29% | 23.16% N/A | |
Operating Margin | -7.13% -60.13% | -17.88% +194.15% | -6.08% -319.11% | 2.77% N/A | |
Return on Assets | -5.71% -39.37% | -9.42% +153.01% | -3.72% -52.41% | -7.82% N/A | |
Return on Equity | -11.72% -38.05% | -18.92% +160.12% | -7.27% -46.89% | -13.70% N/A | |
Revenue Growth | -1.08% -154.22% | 1.99% -50.15% | 3.99% -81.52% | 21.59% N/A | |
Current Ratio | 2.07 +4.73% | 1.98 +1.80% | 1.94 -38.85% | 3.18 N/A | |
Cash Ratio | 1.14 +27.88% | 0.89 -19.15% | 1.10 -10.54% | 1.23 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow